Recruiting Hepatitis B Studies in Hangzhou
About Hepatitis B Clinical Trials in Hangzhou
Hepatitis B is a liver infection caused by the hepatitis B virus that can become chronic and lead to cirrhosis, liver failure, or liver cancer. A vaccine can prevent infection. Treatment for chronic hepatitis B includes antiviral medications that suppress the virus.
There are currently 1 hepatitis b clinical trials recruiting participants in Hangzhou, ZHEJIANG. These studies are seeking a combined 450 participants. Research is being sponsored by GlaxoSmithKline. Clinical trial participation is free and participants receive study-related medical care at no cost.
Hepatitis B Clinical Trials in Hangzhou — FAQ
Are there hepatitis b clinical trials in Hangzhou?
Yes, there are 1 hepatitis b clinical trials currently recruiting in Hangzhou, ZHEJIANG. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Hangzhou?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Hangzhou research site will contact you about next steps.
Are clinical trials in Hangzhou free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Hangzhou studies also compensate for your time and travel.
What hepatitis b treatments are being tested?
The 1 active trials in Hangzhou are testing new therapies including novel drugs, biologics, and treatment approaches for hepatitis b.
Data updated March 2, 2026 from ClinicalTrials.gov